MENU
donate

Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

Jonathan Kessler, MD

City of Hope / Beckman Research Institute
Presented by Minneapolis Metsquerade in memory of Toniya Lucas and Rachael Masters
Combination of Immune Checkpoint Inhibitor and Hepatic Radioembolization for the Treatment of Liver-Dominant Metastatic Breast Cancer
Abstract Report
Summary Report

Tae-Hyung Kim, PhD

University of New Mexico
Harnessing cell mechanotype to regulate the immune evasion of highly metastatic breast cancer cells
Abstract Report
Summary Report

BONNIE KING, PhD and CHRISTOPHER CONTAG, PhD

Stanford University
Modeling Therapeutic Strategies for Breast Cancer Metastasis to Bone
Abstract Report
Summary Report

Efi Kokkotou, MD, PhD, DSc

Beth Israel Deaconess Medical Center
Presented by the Minneapolis Metsquerade
Repurposing a Melanin-concentrating hormone (MCH) antagonist for the treatment of metastatic breast cancer
Abstract Report

Stephen Kron, MD, PhD

The University of Chicago
Mechanisms determining local and systemic anti-tumor immune response after metastasis-directed image-guided radiation combined w
Abstract Report
Summary Report

BALAMURUGAN KUPPUSAMY, PhD

BALAMURUGAN KUPPUSAMY, PhD
This METAvivor funded grant has been accepted and in online as preview in Journal of Clinical Investigation Insight. https://insight.jci.org/in-press-preview
Inflammatory Breast Cancer: Role of the CEBPD-FBXW7 Signaling Pathway
Abstract Report
Summary Report

Carol Lange, PhD

University of Minnesota
Presented In Memory of Rhonda Rhodes, Co-Founder of Metavivor
Targeting Activated Progesterone Receptors in Metastatic Breast Cancer
Abstract Report
Summary Report

Jungwoo Lee, PhD

University of Massachusetts Amherst
Tissue-engineered bone to determine the impact of chemotherapy-induced premature aging in breast tumor metastasis
Abstract Report
Summary Report

Adrian Lee, PhD

University of Pittsburgh, UPMC Hillman Cancer Center
Targeting RET for the treatment of breast cancer brain metastasis
Abstract Report
Summary Report

FRANSISCA LEONARD, PhD

Houston Methodist Hospital Research Institute
CRISPR-nanoparticle for macrophage reprogramming: New therapeutic strategy for breast cancer liver metastasis
Abstract Report

Nancy Lin, MD

Dana-Farber Cancer Institute
Overcoming Treatment Resistance in Breast Cancer Brain Metastases
Abstract Report
Summary Report

Laurie Littlepage, PhD

University of Notre Dame
Targeting Endocrine Therapy Resistance in Bone Metastasis
Abstract Report
donate

SHOP  |  BLOG  |  CALENDAR

Facebook-f Instagram X-twitter Youtube Linkedin-in